H.R. 4244 · 116th Congress
MAGIC Act
- Stage
- In committee
- Sponsor
- Mike Kelly
- Introduced
- 2019-09-09
- Latest action
- 2019-09-10 · Referred to the Subcommittee on Health.
Summary
Market Access for Generic Insulin Competition or the MAGIC Act
This bill provides a pathway for the Food and Drug Administration to approve chemically synthesized insulin or an analogue of chemically synthesized insulin as a generic drug under the abbreviated new drug application process.